![Ye Liu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ye Liu
Amministratore Delegato presso
OCUMENSION THERAPEUTICS
Patrimonio netto: 32 M $ in data 31/05/2026
Profilo
Ye Liu currently works at Ocumension Therapeutics, as Chief Executive Officer & Executive Director from 2018.
Mr. Liu also formerly worked at Santen Pharmaceutical (China) Co. Ltd., as Chairman & General Manager from 2014 to 2018, EyePoint Pharmaceuticals, Inc., as Director from 2021 to 2024, Eisai China, Inc., as General Manager from 2009 to 2014, and Sandoz (China) Pharmaceutical Co., Ltd., as Head-Sales from 2006 to 2009.
Mr. Liu received his graduate degree in 2003 from Dalhousie University and undergraduate degree in 1993 from Zhongshan Hospital Fudan University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 11/09/2025 | 40.918.730 ( 4,89% ) | 32 M $ | 31/05/2026 |
Posizioni attive di Ye Liu
| Società | Posizione | Inizio |
|---|---|---|
| OCUMENSION THERAPEUTICS | Amministratore Delegato | 01/08/2018 |
Precedenti posizioni note di Ye Liu
| Società | Posizione | Fine |
|---|---|---|
| EYEPOINT, INC. | Direttore/Membro del Consiglio | 20/06/2024 |
Santen Pharmaceutical (China) Co. Ltd.
 Santen Pharmaceutical (China) Co. Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales ophthalmic pharmaceuticals | Amministratore Delegato | 01/07/2018 |
Eisai China, Inc.
 Eisai China, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Amministratore Delegato | 01/09/2014 |
Sandoz (China) Pharmaceutical Co., Ltd.
 Sandoz (China) Pharmaceutical Co., Ltd. Pharmaceuticals: GenericHealth Technology Engages in the production of generic pharmaceuticals | Vendite & Marketing | 01/02/2009 |
Formazione di Ye Liu
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
68
Relazioni di 1° grado
7
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
EyePoint Pharmaceuticals, Inc.
 EyePoint Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets ophthalmic pharmaceuticals | Health Technology |
Dalhousie University
 Dalhousie University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Santen Pharmaceutical (China) Co. Ltd.
Santen Pharmaceutical (China) Co. Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales ophthalmic pharmaceuticals | Health Technology |
Eisai China, Inc.
Eisai China, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Zhongshan Hospital Fudan University
 Zhongshan Hospital Fudan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sandoz (China) Pharmaceutical Co., Ltd.
Sandoz (China) Pharmaceutical Co., Ltd. Pharmaceuticals: GenericHealth Technology Engages in the production of generic pharmaceuticals | Health Technology |
Ocumension Therapeutics
 Ocumension Therapeutics Miscellaneous Commercial ServicesCommercial Services Operates as an ophthalmic pharmaceutical platform company that develops drugs | Commercial Services |
